Characterization of human soft-tissue sarcoma and malignant glioma xenografts with particular reference to spontaneous changes during serial passages
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: Immunodeficient mice in oncology: International Symposium, Freiburg, November 1990, S. 60-65
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
1992
- Event
-
Veröffentlichung
- (who)
-
S. Karger AG
- (when)
-
1992
- Creator
- Contributor
-
Fiebig, H.-H.
Berger, D.P.
- DOI
-
10.1159/000421259
- URN
-
urn:nbn:de:bvb:384-opus4-924866
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:56 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dinges, S.
- Budach, V.
- Budach, W.
- Stuschke, M.
- Stüben, Georg
- Bamberg, M.
- Fiebig, H.-H.
- Berger, D.P.
- Universität Augsburg
- S. Karger AG
Time of origin
- 1992
Other Objects (12)
Radiation-induced apoptosis in human sarcoma and glioma cell lines
Molecular adaptation and resistance mechanisms of human malignant glioma cells
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Pirfenidone, an inhibitor of TGF-beta expression in malignant glioma cell lines
Outcome of patients with primary breast sarcoma, radiation-induced sarcoma post breast cancer or Hodgkin lymphoma and malignant phylloides tumours
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
Radiation-induced apoptosis in human sarcoma and glioma cell lines
Molecular adaptation and resistance mechanisms of human malignant glioma cells
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Pirfenidone, an inhibitor of TGF-beta expression in malignant glioma cell lines
Outcome of patients with primary breast sarcoma, radiation-induced sarcoma post breast cancer or Hodgkin lymphoma and malignant phylloides tumours
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
Radiation-induced apoptosis in human sarcoma and glioma cell lines
Molecular adaptation and resistance mechanisms of human malignant glioma cells
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Pirfenidone, an inhibitor of TGF-beta expression in malignant glioma cell lines
Outcome of patients with primary breast sarcoma, radiation-induced sarcoma post breast cancer or Hodgkin lymphoma and malignant phylloides tumours